Active06989197Private limited companyLondon

SUMMIT VETERINARY PHARMACEUTICALS LIMITED

Significant control: Swedencare Ab (Publ) (75–100%)

Companies HouseCompanies House

From public filings as at 31 Aug 2026; may contain errors or be out of date. Verify at Companies House · Terms

Watch this company

Get an email when Companies House records a change for Summit Veterinary Pharmaceuticals Limited: status, filings, accounts, officers or owners. Free.

Not live yet: alerts start by 15 December 2026. We store your email and this company number only, for these alerts. If alerts don’t launch, we tell you and delete your address. Privacy

Coming soon · product and service lists

What does Summit Veterinary Pharmaceuticals Limited sell?

Registered activity: Manufacture of basic pharmaceutical products (SIC 21100). We’re building product and service lists for UK companies. Get this one when it’s ready.

One email, only about this. If we don’t launch within 60 days we’ll tell you. Privacy
01

Summary

Generated from filed data · no estimates

SUMMIT VETERINARY PHARMACEUTICALS LIMITED is an active private limited company (company number 06989197) incorporated on 12 August 2009, registered in London. Its registered activity is manufacture of basic pharmaceutical products (SIC 21100). Latest small accounts cover the period ending 31 December 2025, showing net assets of £5.13m and cash of £1.72m, with 39 employees on average. Net assets rose 41% on the prior period (£3.63m).

Peer position · net assets

By net assets it sits in the top quarter of 143 comparable companies in London (median £100, upper quartile £10k).

02

Ownership and control

1 active · 2 other
  • Swedencare Ab (Publ)
    corporate entity, Sweden · since 1 April 2025
    • owns 75–100% of shares
    • holds 75–100% of voting rights
    • can appoint or remove directors
  • Mrs Laura Michiko Organ
    Individual · since 6 April 2016 · ceased 1 April 2025
    • owns 75–100% of shares
  • Mr Stephen Daniel Organ
    Individual · since 6 April 2016 · ceased 1 April 2025
    • owns 75–100% of shares

Persons with significant control hold 25% or more of shares or voting rights. Smaller shareholdings are only listed in confirmation-statement documents. Directors and secretaries: see the officers list at Companies House.

03

Key dates

Incorporated
12 August 200917 yrs ago
Next accounts due
30 September 2027in 339 days
Confirmation statement due
26 August 2027in 304 days

Due dates are expected from Companies House filing rules; confirm on the official register before relying on them.

04

Activity

SIC 21100
Manufacture of basic pharmaceutical products
Accounts type
Small
Size band
SmallCompanies Act thresholds
05

Financials

2 periods on record · latest ending 31 December 2025
Net assets
£5.13m
+41%vs Mar 2025
Cash at bank
£1.72m
+47406%vs Mar 2025
Turnover
Not reported
Employees
39
−5%vs Mar 2025
Net assets
£5.13m
Cash at bank
£1.72m
Average employees
39
Filed accounts by period, newest first
Period endNet assetsCashDebtorsCreditors <1yTurnoverProfitEmployees
31 December 2025£5.13m£1.72m£1.59m£1.51m——39
31 March 2025£3.63m£3,624£1.37m£894k——41
Current ratio3.46Current assets ÷ creditors within one year
Cash per employee£44kCash ÷ average employees

Figures as filed in iXBRL accounts at Companies House. "—" means the line was not reported in that filing.

06

Filing and accounts signals

Facts from the register · no rating
  • Net assets above zeroNet assets £5,134,015 at 31 December 2025
  • Net assets up 10% or more on the prior period+41.4% vs prior period
  • Current assets at least 1.5× creditors within one yearCurrent ratio 3.46
  • Cash at bank of £50,000 or moreCash £1,721,609
  • Incorporated five or more years agoIncorporated 12 August 2009

Neutral facts read from the register and filed accounts, each with its evidence. They are not a rating, a prediction or advice, and may be incomplete or out of date. How each signal is derived.

07

Timeline

Newest first
  1. Next accounts duein 339 days
  2. Confirmation statement duein 304 days
  3. Accounts period endNet assets £5.13m · small accounts
  4. Accounts period endNet assets £3.63m · small accounts
  5. Incorporated
08

Similar companies in London

Same activity (manufacture of basic pharmaceutical products), closest in incorporation date
09

Reminders for SUMMIT VETERINARY PHARMACEUTICALS LIMITED

Get an email before each filing deadline — accounts and confirmation statement — so nothing is late.

Source: Companies House register, snapshot 2026-08-31; accounts from the Companies House accounts data product. Open Government Licence v3.0. View on Companies House. Methodology · About · Markdown.